Comparison of Outcomes among Chronic Kidney Disease V Patients with COVID-19 at the National Kidney and Transplant Institute: A Retrospective Cohort Study
Table 1
Baseline characteristics of CKD V patients with COVID-19 (n = 436).
All patients (n = 436) n (%)
HD (n = 298) n (%)
PD (n = 103) n (%)
Dialysis initiation (n = 35) n (%)
value
Age (in years), median
52.5 [IQR:40.5–60]
53 [IQR:41–61]
50 [IQR:33–60]
51 [IQR:43–63]
0.1147a
≥60 years
123(28)
86(29)
26(25)
11(31)
0.709b
<60 years
313(72)
212(71)
77(75)
24(69)
Sex
Male
245(56)
167(56)
57(55)
21(60)
0.887b
Female
191(44)
131(44)
46(45)
14(40)
Primary kidney disease, %yes
DM
146(33)
103(35)
36(35)
7(20)
0.211b
Hypertension
123(28)
89(30)
27(26)
7(20)
0.413b
CGN
129(30)
81(27)
35(34)
13(37)
0.254b
Others
40(9)
27(9)
5(5)
8(23)
0.006b
Charlson comorbidity index, median
4 [IQR:3–5]
4 [IQR:3–5]
4 [IQR:3–5]
4 [IQR:3–6]
0.5938a
Chief complaint, %yes
Cough
35(8)
27(9)
5(5)
3(9)
0.397b
Fever
52(12)
41(14)
7(7)
4(11)
0.170b
Myalgia
32(7)
22(7)
6(6)
4(11)
0.546b
Headache
1(1)
1(1)
0
0
1.000c
Difficulty in breathing
187(43)
143(48)
33(32)
11(31)
0.007b
Sore throat
0
0
0
0
—
Diarrhoea
11(3)
5(2)
4(4)
2(6)
0.147c
Nausea
8(2)
5(2)
2(2)
1(3)
0.709c
Loss of smell/taste
51(12)
22(7)
24(23)
5(14)
<0.0001b
Others
214(49)
137(46)
58(56)
19(55)
0.158b
Dialysis duration (in years), median
1 [IQR:0.10–3]
1 [IQR:0.10–3]
0.90 [IQR:0.10–3]
—
0.0689d
Average net fluid removal per week (in ml), median
5376.5 [IQR:2947–7163]
5722 [IQR:3520–7310]
3790 [IQR:1892–5429]
6410 [IQR:1640–9330]
0.0001a
aKruskal–Wallis test was used. Significant results were further analyzed using Dunn’s test; bchi-square test was used; cFisher’s exact test was used; dMann–Whitney U test was used.